| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H18N2O3 |
| Molecular Weight | 274.315 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCNC(=O)C1=CN(COC)C2=C(C=CC=C2)C1=O
InChI
InChIKey=RIPDGZHPNKQLDC-UHFFFAOYSA-N
InChI=1S/C15H18N2O3/c1-3-8-16-15(19)12-9-17(10-20-2)13-7-5-4-6-11(13)14(12)18/h4-7,9H,3,8,10H2,1-2H3,(H,16,19)
| Molecular Formula | C15H18N2O3 |
| Molecular Weight | 274.315 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Terbequinil (previously known as SR 25776), a nootropic agent, is a partial inverse agonist of benzodiazepine receptor with psychostimulant activity. This drug participated in clinical trials for the treatment of cognition disorders and major depressive disorder. However, the development of terbequinil was discontinued during clinical trials in France.
